Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Will Co-Promote Its Imaging Reagents With Mauna Kea's Instruments

NEW YORK (GenomeWeb News) — In vivo cellular-imaging company Mauna Kea Technologies will jointly promote its instruments with Invitrogen reagents.
 
Mauna Kea, headquartered both in Paris and Cambridge, Mass., said the combination of its fluorescent fiber optic microscopy with fluorescent reagents made by Invitrogen division Molecular Probes will allow customers to generate target images in living animals.   
 
Invitrogen said the pairing anticipates greater demand for molecular imaging.
 
Financial terms of the agreement were not released.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.